Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $27.9B |
| FY2017, ended Dec 31, 2017 | $34.4B |
| FY2018, ended Dec 31, 2018 | $37.0B |
| FY2019, ended Dec 31, 2019 | $65.9B |
| FY2020, ended Dec 31, 2020 | $73.7B |
| FY2021, ended Dec 31, 2021 | $125B |
| FY2022, ended Dec 31, 2022 | $104B |
| FY2023, ended Dec 31, 2023 | $123B |
| FY2024, ended Dec 31, 2024 | $98.0B |
| FY2025, ended Dec 31, 2025 | $119B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $123B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.53B |
| FY2017, ended Dec 31, 2017 | $2.62B |
| FY2018, ended Dec 31, 2018 | $2.80B |
| FY2019, ended Dec 31, 2019 | $3.33B |
| FY2020, ended Dec 31, 2020 | $4.44B |
| FY2021, ended Dec 31, 2021 | $4.76B |
| FY2022, ended Dec 31, 2022 | $5.97B |
| FY2023, ended Dec 31, 2023 | $8.02B |
| FY2024, ended Dec 31, 2024 | $8.20B |
| FY2025, ended Dec 31, 2025 | $8.79B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $8.95B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.21B | $1.32B |
| FY2017, ended Dec 31, 2017 | $1.65B | $1.58B |
| FY2018, ended Dec 31, 2018 | $1.65B | $1.71B |
| FY2019, ended Dec 31, 2019 | $1.57B | $469M |
| FY2020, ended Dec 31, 2020 | $1.48B | $1.02B |
| FY2021, ended Dec 31, 2021 | $2.94B | $356M |
| FY2022, ended Dec 31, 2022 | $3.36B | $1.01B |
| FY2023, ended Dec 31, 2023 | $3.06B | $1.97B |
| FY2024, ended Dec 31, 2024 | $3.73B | $1.71B |
| FY2025, ended Dec 31, 2025 | $3.33B | $2.23B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $3.72B | $2.37B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $807M |
| FY2017, ended Dec 31, 2017 | $447M |
| FY2018, ended Dec 31, 2018 | $344M |
| FY2019, ended Dec 31, 2019 | $1.09B |
| FY2020, ended Dec 31, 2020 | $598M |
| FY2021, ended Dec 31, 2021 | $556M |
| FY2022, ended Dec 31, 2022 | $278M |
| FY2023, ended Dec 31, 2023 | $530M |
| FY2024, ended Dec 31, 2024 | $1.32B |
| FY2025, ended Dec 31, 2025 | $1.15B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $861M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $10.6B |
| FY2017, ended Dec 31, 2017 | $9.41B |
| FY2018, ended Dec 31, 2018 | $11.1B |
| FY2019, ended Dec 31, 2019 | $11.9B |
| FY2020, ended Dec 31, 2020 | $16.8B |
| FY2021, ended Dec 31, 2021 | $215M |
| FY2022, ended Dec 31, 2022 | $23.9B |
| FY2023, ended Dec 31, 2023 | $29.0B |
| FY2024, ended Dec 31, 2024 | $30.9B |
| FY2025, ended Dec 31, 2025 | $35.0B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $34.7B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 76.1% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 529M |
| FY2017, ended Dec 31, 2017 | 533M |
| FY2018, ended Dec 31, 2018 | 630M |
| FY2019, ended Dec 31, 2019 | 739M |
| FY2020, ended Dec 31, 2020 | 740M |
| FY2021, ended Dec 31, 2021 | 740M |
| FY2022, ended Dec 31, 2022 | 923M |
| FY2023, ended Dec 31, 2023 | 925M |
| FY2024, ended Dec 31, 2024 | 927M |
| FY2025, ended Dec 31, 2025 | 930M |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | 932M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Paid to employees | Used in acquisitions |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $60.3M | $3.16M |
| FY2017, ended Dec 31, 2017 | $76.6M | — |
| FY2018, ended Dec 31, 2018 | $76.1M | $6.62B |
| FY2019, ended Dec 31, 2019 | $97.6M | — |
| FY2020, ended Dec 31, 2020 | $110M | $48.5M |
| FY2021, ended Dec 31, 2021 | $113M | $130M |
| FY2022, ended Dec 31, 2022 | $175M | — |
| FY2023, ended Dec 31, 2023 | $268M | — |
| FY2024, ended Dec 31, 2024 | $232M | — |
| FY2025, ended Dec 31, 2025 | $185M | — |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $193M | — |
Valuation
At current price- Market Cap
- $118B
- P/E
- 31.7×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 13.2×
- Price / Book
- 2.2×
- EV / EBITDA
- 20.5×
Growth
Trailing 12 months- Revenue (TTM)
- $8.95B
- Revenue Growth YoY
- 6.7%
- Revenue CAGR 3Y
- 13.7%
- Revenue CAGR 5Y
- 14.6%
- EPS Growth YoY
- −0.7%
- Net Income Growth YoY
- −0.6%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 52.4%
- Net Margin
- 41.5%
- FCF Margin
- 26.4%
- Return on Equity
- 7.0%
Earnings
Trailing 12 months- Net Income
- $3.72B
- EPS (diluted)
- $3.98
- EBITDA
- $7.40B
- Operating Income
- $4.69B
Balance Sheet
As of Mar 31, 2026- Cash and cash equivalents
- $861M
- Total Debt
- $34.7B
- Net Debt
- $33.8B
- Total Assets
- $98.1B
- Total Liabilities
- $40.2B
- Shareholders' Equity
- $53.5B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $5.14B
- Capital Expenditure
- $2.77B
- Free Cash Flow
- $2.37B
Dividends and risk
Last 12 months- Dividend Yield
- 3.3%
- Dividend / Share
- $4.22
- Beta (5Y)
- 1.31
Every ratio is calculated from the company’s reported figures.